Resolution of the Expert Council on the topic “Avelumab + axitinib in the 1st line therapy of patients with metastatic renal cell carcinoma. Overall survival in the JAVELIN Renal 101 trial”

Authors

Publication Details

Journal
Cancer Urology
Published
2024-11-24
DOI
https://doi.org/10.17650/1726-9776-2024-20-3-168-171
Citations
1
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Resolution of the Expert Council on the topic “Avelumab + axitinib in the 1st line therapy of patients with metastatic renal cell carcinoma. Overall survival in the JAVELIN Renal 101 trial”

Article Editorial
1 citations
Cancer Urology
Renal cell carcinoma treatment
0.42
article

Resolution of the Expert Council on the topic “Avelumab + axitinib in the 1st line therapy of patients with metastatic renal cell carcinoma. Overall survival in the JAVELIN Renal 101 trial”

Article Editorial
article en
1 citations

Abstract

No abstract available for this paper.
Cancer UrologyVol. 20(3)
Good health and well-being
Openalex Percentile: Top 30%
Renal cell carcinoma treatment
0.42
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Resolution of the Expert Council on the topic “Avelumab + axitinib in the 1st line therapy of patients with metastatic renal cell carcinoma. Overall survival in the JAVELIN Renal 101 trial” — Article Editorial · Cancer Urology (2024) | TGRS Research Map | TGRS